Horizons Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$35.8K Sell
298
-46
-13% -$5.31K 0.02% 113
2025
Q4
$36.2K Hold
344
0.02% 113
2025
Q3
$28.9K Sell
344
-27
-7% -$2.22K 0.02% 120
2025
Q2
$29.4K Sell
371
-32
-8% -$2.54K 0.02% 118
2025
Q1
$36.2K Hold
403
0.03% 111
2024
Q4
$40.1K Hold
403
0.03% 103
2024
Q3
$45.8K Sell
403
-81
-17% -$9.62K 0.04% 101
2024
Q2
$60.9K Hold
484
0.05% 91
2024
Q1
$52.8K Hold
484
0.03% 89
2023
Q4
$52.8K Hold
484
0.03% 89
2023
Q3
$49.8K Hold
484
0.04% 88
2023
Q2
$55.8K Buy
484
+27
+6% +$3.07K 0.04% 88
2023
Q1
$48.6K Hold
457
0.04% 88
2022
Q4
$51K Hold
457
0.04% 89
2022
Q3
$39K Hold
457
0.04% 85
2022
Q2
$42K Buy
+457
New +$40.5K 0.03% 88

Other funds holding MRK

Horizons Wealth Management's MRK Position: Q1 2026 in Review

Horizons Wealth Management reduced its Merck (MRK) stake by 13% in Q1 2026, selling an estimated $5.31K and leaving 298 shares worth $35.8K. The position accounts for 0.02% of the portfolio, ranked #113.

Horizons Wealth Management first reported a position in MRK in Q2 2022 and has held it in 16 quarters since. The position peaked at $60.9K in Q2 2024. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Horizons Wealth Management held 298 shares of Merck worth $35.8K as of Q1 2026.
  • Horizons Wealth Management sold 46 Merck shares in Q1 2026, an estimated $5.31K.
  • Merck made up 0.02% of Horizons Wealth Management's portfolio in Q1 2026, its #113 holding.
  • Horizons Wealth Management first reported a position in Merck in Q2 2022 and has held it in 16 quarters since.
  • Horizons Wealth Management's Merck position peaked at $60.9K in Q2 2024.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Horizons Wealth Management's 13F filing for Q1 2026, filed 2 Apr 2026.